Search results
13 cze 2020 · Specific treatments depend on the type and severity of your pneumonia, your age and your overall health. The options include: Antibiotics. These medicines are used to treat bacterial pneumonia. It may take time to identify the type of bacteria causing your pneumonia and to choose the best antibiotic to treat it.
9 sty 2017 · Statins have great potential since recent studies involving both human and animal models suggest that they have anti‐inflammatory and immunomodulatory effects that might control the host immune response to conditions like severe influenza and pneumonia through prevention of excess cytokine release.
27 maj 2023 · Statins include atorvastatin (Lipitor), fluvastatin (Lescol XL), lovastatin (Altoprev), pitavastatin (Livalo), pravastatin, rosuvastatin (Crestor) and simvastatin (Zocor). Having too much cholesterol in the blood increases the risk of heart attacks and strokes. Statins block an enzyme the liver needs to make cholesterol.
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Possible mechanisms of statin action against influenza A virus pathogenesis in cellular and molecular structures. 3. In Vitro Study. Statins represent one of the most widely prescribed drugs in the world; therefore, identifying their capacity to reduce influenza virus mortality and morbidity during a pandemic is a matter of public health importance.
7 sty 2013 · Abstract. Background. Emerging epidemiological evidence suggests that statins may reduce the risk of community-acquired pneumonia (CAP) and its complications. Purpose. Performed a systematic review to address the role of statins in the prevention or treatment of CAP. Data Source.
1 cze 2021 · The rate of laboratory confirmed influenza was significantly higher in unvaccinated statin users (adjusted odds ratio (AOR), 2.44; 95% CI: 1.06-5.62) compared to unvaccinated non-users. The VE was 98% overall, and not significantly different between statin users (92.4%) and non-statin users (100%).
